Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Conformis, Inc. stock logo
CFMS
Conformis
$2.26
$2.25
$1.05
$7.25
$17.80M1.3999,585 shs7,000 shs
Heart Test Laboratories, Inc. stock logo
HSCS
Heart Test Laboratories
$3.65
+0.3%
$3.33
$2.36
$7.57
$3.95M2.6116,888 shs26,127 shs
Nutriband Inc. stock logo
NTRB
Nutriband
$6.46
+2.4%
$5.64
$3.72
$11.78
$72.06M1.18142,837 shs39,539 shs
Predictive Oncology Inc. stock logo
POAI
Predictive Oncology
$0.91
+0.6%
$1.11
$0.55
$3.06
$8.13M1.31.94 million shs112,896 shs
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Conformis, Inc. stock logo
CFMS
Conformis
0.00%0.00%0.00%0.00%0.00%
Heart Test Laboratories, Inc. stock logo
HSCS
Heart Test Laboratories
-14.95%-6.67%+8.66%-2.15%-43.21%
Nutriband Inc. stock logo
NTRB
Nutriband
+5.52%+17.72%+8.05%-12.48%+19.06%
Predictive Oncology Inc. stock logo
POAI
Predictive Oncology
0.00%-16.97%-14.62%-34.89%-56.59%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Conformis, Inc. stock logo
CFMS
Conformis
N/AN/AN/AN/AN/AN/AN/AN/A
Heart Test Laboratories, Inc. stock logo
HSCS
Heart Test Laboratories
2.5284 of 5 stars
3.53.00.00.02.70.01.3
Nutriband Inc. stock logo
NTRB
Nutriband
2.278 of 5 stars
3.52.00.00.02.51.70.6
Predictive Oncology Inc. stock logo
POAI
Predictive Oncology
2.5874 of 5 stars
3.05.00.00.02.50.01.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Conformis, Inc. stock logo
CFMS
Conformis
0.00
N/AN/AN/A
Heart Test Laboratories, Inc. stock logo
HSCS
Heart Test Laboratories
3.00
Buy$13.00256.16% Upside
Nutriband Inc. stock logo
NTRB
Nutriband
3.00
Buy$13.00101.24% Upside
Predictive Oncology Inc. stock logo
POAI
Predictive Oncology
2.00
Hold$3.00229.67% Upside

Current Analyst Ratings Breakdown

Latest CFMS, POAI, HSCS, and NTRB Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/18/2025
Heart Test Laboratories, Inc. stock logo
HSCS
Heart Test Laboratories
Ascendiant Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$15.00 ➝ $14.00
(Data available from 5/29/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Conformis, Inc. stock logo
CFMS
Conformis
$57.06M0.31N/AN/A$4.07 per share0.56
Heart Test Laboratories, Inc. stock logo
HSCS
Heart Test Laboratories
$14.70K268.41N/AN/A$11.16 per share0.33
Nutriband Inc. stock logo
NTRB
Nutriband
$2.14M33.68N/AN/A$0.73 per share8.85
Predictive Oncology Inc. stock logo
POAI
Predictive Oncology
$1.73M4.70N/AN/A$2.04 per share0.45
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Conformis, Inc. stock logo
CFMS
Conformis
-$50.47M-$5.61N/AN/AN/A-72.72%-86.46%-47.65%N/A
Heart Test Laboratories, Inc. stock logo
HSCS
Heart Test Laboratories
-$6.61M-$7.48N/AN/AN/AN/A-117.76%-84.09%8/4/2025 (Estimated)
Nutriband Inc. stock logo
NTRB
Nutriband
-$5.49M-$0.99N/AN/AN/A-338.51%-54.49%-48.52%5/30/2025 (Estimated)
Predictive Oncology Inc. stock logo
POAI
Predictive Oncology
-$13.98M-$3.05N/AN/AN/A-1,012.32%-286.30%-122.11%8/12/2025 (Estimated)

Latest CFMS, POAI, HSCS, and NTRB Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/30/2025N/A
Nutriband Inc. stock logo
NTRB
Nutriband
-$0.13N/AN/AN/A$0.71 millionN/A
5/14/2025Q1 2025
Predictive Oncology Inc. stock logo
POAI
Predictive Oncology
-$0.09-$0.32-$0.23-$0.34$1.50 million$0.11 million
4/28/2025Q4 2025
Nutriband Inc. stock logo
NTRB
Nutriband
-$0.12-$0.18-$0.06-$0.51$0.71 million$0.64 million
3/13/2025Q3 2025
Heart Test Laboratories, Inc. stock logo
HSCS
Heart Test Laboratories
-$2.53-$2.5722-$0.0422-$2.57N/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Conformis, Inc. stock logo
CFMS
Conformis
N/AN/AN/AN/AN/A
Heart Test Laboratories, Inc. stock logo
HSCS
Heart Test Laboratories
N/AN/AN/AN/AN/A
Nutriband Inc. stock logo
NTRB
Nutriband
N/AN/AN/AN/AN/A
Predictive Oncology Inc. stock logo
POAI
Predictive Oncology
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Conformis, Inc. stock logo
CFMS
Conformis
0.64
5.07
3.30
Heart Test Laboratories, Inc. stock logo
HSCS
Heart Test Laboratories
0.01
1.72
1.52
Nutriband Inc. stock logo
NTRB
Nutriband
0.01
4.96
4.83
Predictive Oncology Inc. stock logo
POAI
Predictive Oncology
N/A
1.20
1.06

Institutional Ownership

CompanyInstitutional Ownership
Conformis, Inc. stock logo
CFMS
Conformis
10.31%
Heart Test Laboratories, Inc. stock logo
HSCS
Heart Test Laboratories
17.24%
Nutriband Inc. stock logo
NTRB
Nutriband
19.70%
Predictive Oncology Inc. stock logo
POAI
Predictive Oncology
9.04%

Insider Ownership

CompanyInsider Ownership
Conformis, Inc. stock logo
CFMS
Conformis
3.80%
Heart Test Laboratories, Inc. stock logo
HSCS
Heart Test Laboratories
1.80%
Nutriband Inc. stock logo
NTRB
Nutriband
54.09%
Predictive Oncology Inc. stock logo
POAI
Predictive Oncology
3.44%
CompanyEmployeesShares OutstandingFree FloatOptionable
Conformis, Inc. stock logo
CFMS
Conformis
2957.88 million7.58 millionNot Optionable
Heart Test Laboratories, Inc. stock logo
HSCS
Heart Test Laboratories
101.08 million962,000Not Optionable
Nutriband Inc. stock logo
NTRB
Nutriband
1011.15 million5.10 millionNot Optionable
Predictive Oncology Inc. stock logo
POAI
Predictive Oncology
308.93 million6.44 millionNot Optionable

Recent News About These Companies

Renovaro says Predictive Oncology terminated merger agreement
Top 8 AI News Updates Driving Markets Today

New MarketBeat Followers Over Time

Media Sentiment Over Time

Conformis stock logo

Conformis NASDAQ:CFMS

Conformis, Inc., a medical technology company, develops, manufactures, and sells patient-specific products and instrumentation. The company offers personalized knee replacement products, including iUni, iDuo, iTotal CR, and iTotal PS, as well as provides iTotal Identity and Identity Imprint knee replacement products. It also offers Conformis Hip System and Cordera hip replacement, which are hip replacement products; and iJigs, a personalized single-use patient-specific instrumentation. The company markets and sells its products to orthopedic surgeons, hospitals, and other medical facilities through sales force, independent sales representatives, and distributors in the United States, Germany, the United Kingdom, Austria, Ireland, Switzerland, Spain, Portugal, the Netherlands, Belgium, the Dutch Antilles, Suriname, Australia, Brazil, the United Arab Emirates, the Sultanate of Oman, Italy, Poland, and other markets. Conformis, Inc. was incorporated in 2004 and is headquartered in Billerica, Massachusetts.

Heart Test Laboratories stock logo

Heart Test Laboratories NASDAQ:HSCS

$3.65 +0.01 (+0.27%)
Closing price 03:57 PM Eastern
Extended Trading
$3.68 +0.02 (+0.68%)
As of 04:12 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.

Nutriband stock logo

Nutriband NASDAQ:NTRB

$6.46 +0.15 (+2.38%)
Closing price 04:00 PM Eastern
Extended Trading
$6.50 +0.04 (+0.62%)
As of 04:27 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. The company also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility. It has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices; and Kindeva Drug Delivery, L.P. to develop AVERSAL Fentanyl based on its proprietary AVERSAL abuse deterrent transdermal technology. The company was incorporated in 2016 and is headquartered in Orlando, Florida.

Predictive Oncology stock logo

Predictive Oncology NASDAQ:POAI

$0.91 +0.01 (+0.55%)
Closing price 04:00 PM Eastern
Extended Trading
$0.90 -0.01 (-1.32%)
As of 04:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Predictive Oncology Inc. operates as a science-driven company on the oncology drug discovery. It provides various solutions for the oncology drug development. The company, through the integration of scientific rigor and machine learning, has developed the ability to advance molecules into medicine by introducing human diversity earlier into the discovery process with the pairing of artificial intelligence and the biobank of approximately 150K tumor samples. It operates through four segments: Helomics, zPREDICTA, Soluble, and Skyline. The Helomics segment provides services that include the application of AI, collaboration projects, and clinical testing. The zPREDICTA segment develops organ-specific disease models that provide 3D reconstruction of human tissues representing each disease state and mimicking drug response for testing of anticancer agents. The Soluble segment provides services using a self-contained automated system that conducts self-interaction chromatography screens using additives and excipients included in protein formulations resulting in soluble and physically stable formulations for biologics. This segment also offers protein stability analysis services; protein solubility kits that allow rapid identification of soluble formulations; and proprietary technologies for bacterial endotoxin detection and removal. The Skyline segment provides STREAMWAY System, a wall-mounted fully automated system, which virtually eliminates exposure to blood, irrigation fluid, and other infectious fluids found in the healthcare environment. The company was formerly known as Precision Therapeutics Inc. and changed its name to Predictive Oncology Inc. in June 2019. Predictive Oncology Inc. was incorporated in 2002 and is headquartered in Eagan, Minnesota.